Cilostazol reduces morbidity but not mortality secondary to cerebral vasospasm following aneurysmal subarachnoid hemorrhage

Journal of the Neurological Sciences

Volumn 340, Issue 1-2, 2014, Pages 243-244

  Ding, Dale ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cerebral vasospasm; Cilostazol; Intracranial aneurysm; Stroke; Subarachnoid hemorrhage

Indexed keywords

CILOSTAZOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; GUANYLATE CYCLASE; NICARDIPINE; NITRIC OXIDE; PHOSPHODIESTERASE III; NEUROPROTECTIVE AGENT; TETRAZOLE DERIVATIVE;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BRAIN INFARCTION; BRAIN VASOSPASM; CALCIUM TRANSPORT; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR SPACE; FOLLOW UP; HUMAN; LETTER; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SMOOTH MUSCLE FIBER; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULITIS; VASOCONSTRICTION; VASODILATATION; INTRACRANIAL ANEURYSM;

HUMANS; INTRACRANIAL ANEURYSM; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE; TETRAZOLES;

EID: 84899902001     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.03.017     Document Type: Letter

References (19)

1. P.P. Niu, G. Yang, Y.Q. Xing, Z.N. Guo, and Y. Yang Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis J Neurol Sci 336 1-2 2014 146 151
2. A.K. Rao, V.R. Vaidyula, S. Bagga, G. Jalagadugula, J. Gaughan, and D.B. Wilhite et al. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease Thromb Haemost 96 6 2006 738 743
3. S.C. Stein, K.D. Browne, X.H. Chen, D.H. Smith, and D.I. Graham Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study Neurosurgery 59 4 2006 781 787 [discussion 787-8]
4. A. Hashimoto, G. Miyakoda, Y. Hirose, and T. Mori Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism Atherosclerosis 189 2 2006 350 357
5. Y. Kawanabe, M. Takahashi, X. Jin, S. Abdul-Majeed, A.M. Nauli, and Y. Sari et al. Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation PLoS One 7 9 2012 e44476
6. N. Shimamura, and H. Ohkuma Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage Transl Stroke Res 2013 (Electronic publication ahead of print 2013 Nov 20)
7. R.M. Starke, N. Chalouhi, D. Ding, D.M. Raper, M.S. McKisic, and G.K. Owens et al. Vascular smooth muscle cells in cerebral aneurysm pathogenesis Transl Stroke Res 2013 (Electronic publication ahead of print 2013 Oct 10)
8. B.A. Gross, P.M. Rosalind Lai, K.U. Frerichs, and R. Du Treatment modality and vasospasm after aneurysmal subarachnoid hemorrhage World Neurosurg 2013 (Electronic publication ahead of print 2013 Aug 14)
9. A. Molyneux, R. Kerr, I. Stratton, P. Sandercock, M. Clarke, and J. Shrimpton et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial Lancet 360 9342 2002 1267 1274
10. C.G. McDougall, R.F. Spetzler, J.M. Zabramski, S. Partovi, N.K. Hills, and P. Nakaji et al. The barrow ruptured aneurysm trial J Neurosurg 116 1 2012 135 144
11. R.F. Spetzler, C.G. McDougall, F.C. Albuquerque, J.M. Zabramski, N.K. Hills, and S. Partovi et al. The barrow ruptured aneurysm trial: 3-year results J Neurosurg 119 1 2013 146 157
12. H. Li, R. Pan, H. Wang, X. Rong, Z. Yin, and D.P. Milgrom et al. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis Stroke 44 1 2013 29 37
13. R.Q. Huang, F.G. Jiang, Z.M. Feng, and T.Y. Wang Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data Acta Neurol Belg 113 1 2013 3 6
14. R.L. Macdonald, R.T. Higashida, E. Keller, S.A. Mayer, A. Molyneux, and A. Raabe et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling Stroke 43 6 2012 1463 1469
15. R.L. Macdonald, R.T. Higashida, E. Keller, S.A. Mayer, A. Molyneux, and A. Raabe et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) Lancet Neurol 10 7 2011 618 625
16. R.L. Macdonald, R.M. Pluta, and J.H. Zhang Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution Nat Clin Pract Neurol 3 5 2007 256 263
17. K.P. Budohoski, M. Czosnyka, P.J. Kirkpatrick, P. Smielewski, L.A. Steiner, and J.D. Pickard Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage Nat Rev Neurol 9 3 2013 152 163
18. R.L. Macdonald Delayed neurological deterioration after subarachnoid haemorrhage Nat Rev Neurol 10 1 2014 44 58
19. S.A. Mayer, K.T. Kreiter, D. Copeland, G.L. Bernardini, J.E. Bates, and S. Peery et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage Neurology 59 11 2002 1750 1758